Jump to content

PubMed RSS Feed - - An Emerging Treatment: Topical Ivermectin for Papulopustular Rosacea.


Recommended Posts

An Emerging Treatment: Topical Ivermectin for Papulopustular Rosacea.

J Dermatolog Treat. 2014 Nov 26;:1-8

Authors: Abokwidir M, Fleischer AB

Abstract Ivermectin shows broad-spectrum anti-parasitic activity. It kills the Demodex mites that reside in the pilosebaceous units of patients with papulopustular rosacea. Ivermectin also has anti-inflammatory effects, it decreases cellular and humoral immune responses. Inflammatory mechanisms appear to play a dominant role in development of rosacea inflammatory lesions. Additionally, there is some evidence that it has antimicrobial activity, against Myobacterium tuberculosis and Chlamydia trachomatis. In recent clinical studies of ivermectin on rosacea show that it was superior to vehicle in reducing inflammatory lesion counts, and tolerability was excellent.Ivermectin displays antimicrobial, antiparasitic, antibacterial, and anti-inflammatory activities.

PMID: 25424053 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/25424053?dopt=Abstract = URL to article

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...